Author: Tom Cohen
-
On Mental Health: Off the Meds
I’ve written previously about my struggle with anxiety, how I initially used CBT as a coping strategy, that field’s roots in stoicism, and how ultimately, I wanted to find a new way of managing. It’s been nearly three years since I published that post and the path I ended up taking did not get to…
-
GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
GHR’s total investment in C2N has now broken $50 million since 2020. Read More
-
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network. Read More
-
New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development
The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota. Read More
-
Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery
The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process. Read More
-
National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique
The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space. Read More
-
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of ParaÃba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU. Read More
-
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU. Read More
-
AI analysis of patient serum presents promising new Lyme disease diagnosis tool
The AI-enabled immunological approach aims to bring accurate diagnoses faster and sooner after potential infection. Read More
-
Regeneron’s Bispecific Gets EU Approval After FDA Rejection
The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU. Read More